Showing results (31-40 of 217) with videos related to

Sort By:
Pageof 22
Anticancer Research|July 24, 2010
AKT and p21 WAF1/CIP1 as potential genistein targets in BRCA1-mutant human breast cancer cell linesMaud Privat, Corinne Aubel, Stephanie Arnould, et al.
Cancers|November 2, 2018
Breaking down the Contradictory Roles of Histone Deacetylase SIRT1 in Human Breast CancerKhaldoun Rifaï, Mouhamed Idrissou, Frédérique Penault-Llorca, et al.
Journal of Geriatric Cardiology : JGC|July 12, 2012
Insights into restrictive cardiomyopathy from clinical and animal studiesPierre-Yves Jean-Charles, Yue-Jin Li, Chang-Long Nan, et al.
Epigenomics|May 13, 2020
Epi-drugs as triple-negative breast cancer treatmentMouhamed Idrissou, Anna Sanchez, Frédérique Penault-Llorca, et al.
Molecular Carcinogenesis|November 20, 2016
Anti-EGFR monoclonal antibodies enhance sensitivity to DNA-damaging agents in BRCA1-mutated and PTEN-wild-type triple-negative breast cancer cellsAbderrahim El Guerrab, Mahchid Bamdad, Yves-Jean Bignon, et al.
Scientific Reports|April 15, 2020
Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cellsAbderrahim El Guerrab, Mahchid Bamdad, Yves-Jean Bignon, et al.
Biochemical and Biophysical Research Communications|January 8, 2009
Breast cancer cell response to genistein is conditioned by BRCA1 mutationsMaud Privat, Corinne Aubel, Stéphanie Arnould, et al.
Nutrition and Cancer|January 26, 2010
Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolismsLaetitia Delort, Samir Satih, Fabrice Kwiatkowski, et al.
Pageof 22